Ionis Pharmaceuticals Inc (STU:ISI)
€ 34.62 0.13 (0.38%) Market Cap: 5.44 Bil Enterprise Value: 4.45 Bil PE Ratio: 0 PB Ratio: 8.55 GF Score: 59/100

Ionis Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 12, 2023 / 04:15PM GMT
Release Date Price: €40.45 (+5.53%)
Michael Eric Ulz;Brett P. Monia
Morgan Stanley, Research Division - Equity Analyst;Ionis

All right. Good afternoon, everyone, and thanks for joining us at the Morgan Stanley Global Healthcare Conference. I'm Mike Ulz, one of the biotech analysts here, and it's my pleasure to introduce Brett Monia, CEO of Ionis Pharmaceuticals.

Just a reminder, the format for today is a fireside chat. If anyone in the audience would like to ask a question, please raise your hand, and we will get your question addressed.

Before we get started, I just need to read a quick disclosure statement. For important disclosures, please see the Morgan Stanley Research Disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.

With that, Brett, thanks for sharing your time with us today. And maybe you can kick us off here with just some introductory comments and we'll get into Q&A.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot